Optical Techniques Offer Fast, Efficient COVID-19 Detection

Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need. Researchers investigated the opportunities and challenges in developing rapid COVID-19 sensing techniques and discuss the prospects of optical biosensors for point-of-care COVID-19 testing in the journal Applied Physics Reviews.

AACC and CDC Partner to Improve Cardiovascular Disease Testing Around the World

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation that aims to expand lipid testing in resource-limited countries. Improving access to this essential testing could help reduce the high worldwide mortality rate from cardiovascular disease by enabling patients to get treated for this condition earlier.

NIH continues to boost national COVID-19 testing capacity

NIH today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its RADx initiative. NIH is awarding contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.

AACC Releases Guidance Document on Using Point-of-Care Tests to Improve Patient Care

AACC has issued a new guidance document detailing best practices that hospitals and other healthcare institutions should follow when running a point-of-care testing program. As point-of-care tests emerge for more and more conditions—including COVID-19—the guidance emphasizes that it is essential for laboratory professionals and clinicians to collaborate on point-of-care testing programs to ensure this testing benefits patients.